Search

Your search keyword '"Hueppe, Dietrich"' showing total 116 results
Start Over Author "Hueppe, Dietrich"
116 results on '"Hueppe, Dietrich"'

1. A multicenter randomized-controlled trial of nucleos(t)ide analogue cessation in HBeAg-negative chronic hepatitis B

Author

van Bömmel, Florian, Stein, Kerstin, Heyne, Renate, Petersen, Jörg, Buggisch, Peter, Berg, Christoph, Zeuzem, Stefan, Stallmach, Andreas, Sprinzl, Martin, Schott, Eckart, Pathil-Warth, Anita, von Arnim, Ulrike, Keitel, Verena, Lohmeyer, Jürgen, Simon, Karl-Georg, Trautwein, Christian, Trein, Andreas, Hüppe, Dietrich, Cornberg, Markus, Lammert, Frank, Ingiliz, Patrick, Zachoval, Reinhart, Hinrichsen, Holger, Zipprich, Alexander, Klinker, Hartmuth, Schulze zur Wiesch, Julian, Schmiedeknecht, Anett, Brosteanu, Oana, and Berg, Thomas

Published
2023
Full Text
View/download PDF

2. Patterns of Resistance-Associated Substitutions in Patients With Chronic HCV Infection Following Treatment With Direct-Acting Antivirals

Author

Antoni, C., Vogelmann, R., Ebert, M., Backhus, J., Seufferlein, T., Balavoine, J., Giostra, E., Berg, C., Cornberg, M., Wedemeyer, H., Manns, M., De Gottardi, A., Esteban, R., Discher, T., Roeb, E., Gress, M., Günther, R., Wietzke-Braun, P., Herrmann, A., Stallmach, A., Hoffmann, D., Klinker, H., Kodal, A., Lammert, F., Löbermann, M., Schulze zur Wiesch, J., von Felden, J., Piecha, F., Lohse, A., Götze, T., Malfertheiner, P., Mayerle, J., Moradpour, D., Moreno, C., Neumann-Haefelin, C., Thimme, R., Reinhardt, L., Ellenrieder, V., Schattenberg, J., Sprinzl, M., Galle, P., Schmidt, J., Schott, E., Epple, H.-J., Siebler, J., Stauber, R., Steckstor, M., Schmiegel, W., Stremmel, W., Strey, B., Tomasiewicz, K., Trautwein, C., Zachoval, R., Angeli, W., Beckebaum, S., Doberauer, C., Ende, K., Erhardt, A., Garrido-Lüneburg, A., Gattringer, H., Genné, D., Gschwantler, M., Gundling, F., Hartmann, C., Heyer, T., Hirschi, C., Kanzler, S., Kordecki, N., Kraus, M., Kullig, U., Magenta, L., Terziroli Beretta-Piccoli, B., Menges, M., Mohr, L., Muehlenberg, K., Niederau, C., Paulweber, B., Petrides, A., Piso, R., Rambach, W., Reiser, M., Riecken, B., Roth, J., Schöfl, R., Maieron, A., Schneider, A., Schuchmann, M., Schulten-Baumer, U., Seelhoff, A., Semela, D., Stich, A., Vollmer, C., Brückner, J., Ungemach, J., Walter, E., Weber, A., Winzer, T., Abels, W., Adler, M., Audebert, F., Baermann, C., Bästlein, E., Barth, R., Barthel, K., Baumgartl, K., Becker, W., Benninger, J., Beyer, T., Bodtländer, A., Böhm, G., Bohr, U., Moll, A., Naumann, U., Börner, N., Bruch, H.R., Busch, N., Burkhard, O., Chirca, C., Dienethal, A., Dietel, P., Dreher, F., Efken, P., Ehrle, U., Emke, F., Fischer, J., Fischer, U., Frederking, D., Frick, B., Gantke B, B., Geyer, P., Glaunsinger, T., Goebel, F., Göbel, U., Graf, R., Herder, M., Heuchel, T., Heuer, S., Heyne, R., Höffl, K.H., Hofmann, W.P., Holst, F., Hörster, H., John, C., Jung, M.C., Kallinowski, B., Kerzel, W., Khaykin, P., Klarhof, M., Knapp, B., Knevels, U., Körfer, A., Köster, A., Künzig, B., Langenkamp, A., Kuhn, M., Littman, M., Löhr, H., Ludwig, L., Lutz, U., Maurer, P., Mayer, C., Meister, V., Moritzen, D., Mroß, M., Mundlos, M., Nehls, O., Ningel, K., Oelmann, A., Olejnik, H., Pascher, E., Philipp, A., Pichler, M., Polzien, F., Raddant, R., Riedel, M., Rietzler, S., Rump, A., Schmidt, W., Schmidtler-von Fabris, J., Schneider, L., Schober, A., Schwenzer, J., Seidel, T., Seitel, G., Sick, C., Simon, K., Stähler, D., Steffens, H., Svensson, K., Tacke, W., Teubner, K., Thieringer, J., Trappe, U., Ullrich, J., Usadel, S., von Lucadou, A., Werheid-Dobers, M., Zehnter, E., Zipf, A., Dietz, Julia, Susser, Simone, Vermehren, Johannes, Peiffer, Kai-Henrik, Grammatikos, Georgios, Berger, Annemarie, Ferenci, Peter, Buti, Maria, Müllhaupt, Beat, Hunyady, Bela, Hinrichsen, Holger, Mauss, Stefan, Petersen, Jörg, Buggisch, Peter, Felten, Gisela, Hüppe, Dietrich, Knecht, Gaby, Lutz, Thomas, Schott, Eckart, Berg, Christoph, Spengler, Ulrich, von Hahn, Thomas, Berg, Thomas, Zeuzem, Stefan, and Sarrazin, Christoph

Published
2018
Full Text
View/download PDF

5. Sofosbuvir and Ledipasvir for 8 Weeks for the Treatment of Chronic Hepatitis C Virus (HCV) Infection in HCV-Monoinfected and HIV-HCV–Coinfected Individuals: Results From the German Hepatitis C Cohort (GECCO-01)

Author

Ingiliz, Patrick, Christensen, Stefan, Kimhofer, Torben, Hueppe, Dietrich, Lutz, Thomas, Schewe, Knud, Busch, Heiner, Schmutz, Günther, Wehmeyer, Malte H., Boesecke, Christoph, Simon, Karl-Georg, Berger, Florian, Rockstroh, Jürgen K., zur Wiesch, Julian Schulze, Baumgarten, Axel, and Mauss, Stefan

Published
2016
Full Text
View/download PDF

6. Real‐world effectiveness of sofosbuvir‐based treatment regimens for chronic hepatitis C genotype 3 infection: Results from the multicenter German hepatitis C cohort (GECCO‐03)

Author

Wehmeyer, Malte H., Ingiliz, Patrick, Christensen, Stefan, Hueppe, Dietrich, Lutz, Thomas, Simon, Karl Georg, Schewe, Knud, Boesecke, Christoph, Baumgarten, Axel, Busch, Heiner, Rockstroh, Juergen, Schmutz, Guenther, Kimhofer, Torben, Berger, Florian, Mauss, Stefan, and Schulze zur Wiesch, Julian

Published
2018
Full Text
View/download PDF

7. Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A 3-Year Prospective Field Practice Study in Germany

Author

Petersen, Jörg, Heyne, Renate, Mauss, Stefan, Schlaak, Jörg, Schiffelholz, Willibald, Eisenbach, Christoph, Hartmann, Heinz, Wiese, Manfred, Boeker, Klaus, Loehr, Hanns-Friedrich, John, Christine, Leuschner, Maria, Trautwein, Christian, Felten, Gisela, Trein, Andreas, Krause, Wolfgang, Ruppert, Susanne, Warger, Tobias, and Hueppe, Dietrich

Published
2016
Full Text
View/download PDF

12. TOP-110 - Increasing functional cure rate beyond 96 weeks after discontinuation of nucleos (t)ide analogue treatment in HBeAg-negative chronic hepatitis B: follow-up of the stop-NUC trial

Author

van Bömmel, Florian, Stein, Kerstin, Heyne, Renate, Petersen, Jörg, Buggisch, Peter, Berg, Christoph, Zeuzem, Stefan, Stallmach, Andreas, Sprinzl, Martin, Schott, Eckart, Pathil-Warth, Anita, von Arnim, Ulrike, Keitel, Verena, Lohmeyer, Jürgen, Georg, Simon Karl, Trautwein, Christian, Trein, Andreas, Hüppe, Dietrich, Cornberg, Markus, Lammert, Frank, Ingiliz, Patrick, Zachoval, Reinhart, Hinrichsen, Holger, Zipprich, Alexander, Klinker, Hartwig, zur Wiesch, Julian Schulze, Schmiedeknecht, Anett, Brosteanu, Oana, and Berg, Thomas

Published
2023
Full Text
View/download PDF

14. Hepatitis C population in Germany, changing over time: 958

Author

Klass, Dietmar M., Hinrichsen, Holger, Boeker, Klaus H., Teuber, Gerlinde, Naumann, Uwe, von Lucadou, Armand, Antoni, Christoph, Jung, Maria-Christina, Ullrich, Rainer, Herrmann, Andreas, Weber, Andreas, Gösseringer, Roger, Hueppe, Dietrich, and Mauss, Stefan

Published
2012

22. Profound hepatitis b virus suppression with favorable tolerability by tenofovir in field practice - interim results from the prospective multicenter non-interventional study “geminis”: 413

Author

Petersen, Joerg, Heyne, Renate, Mauss, Stefan, Schlaak, Joerg F., Schiffelholz, Willibold, Eisenbach, Christoph, Hartmann, Heinz, Wiese, Manfred, Boeker, Klaus H., Loehr, Hanns-Friedrich F., John, Christine, Leuschner, Maria S., Trautwein, Christian, Ruppert, Susanne, Warger, Tobias, and Hueppe, Dietrich

Published
2012

23. Reinfection With the Hepatitis C Virus in Men Who Have Sex With Men After Successful Treatment With Direct-acting Antivirals in Germany: Current Incidence Rates, Compared With Rates During the Interferon Era.

Author

Ingiliz, Patrick, Wehmeyer, Malte H, Boesecke, Christoph, Wiesch, Julian Schulze Zur, Schewe, Knud, Lutz, Thomas, Baumgarten, Axel, Simon, Karl-Georg, Hueppe, Dietrich, Rockstroh, Juergen K, Mauss, Stefan, Christensen, Stefan, Group, European AIDS Treatment Network (NEAT) Study, and Group, German Hepatitis C Cohort (GECCO) Study

Subjects
HEPATITIS C risk factors, THERAPEUTIC use of interferons, ANTIVIRAL agents, INFECTIOUS disease transmission, CONFIDENCE intervals, HEPATITIS C, MULTIVARIATE analysis, TIME, DISEASE relapse, MEN who have sex with men, DESCRIPTIVE statistics, DISEASE eradication, ODDS ratio, DISEASE risk factors
Abstract

Background Micro-elimination of the hepatitis C virus (HCV) includes treatment in populations at risk of ongoing HCV transmission, such as men who have sex with men (MSM) or people who inject drugs (PWID). We analyzed the HCV reinfection incidence rates of participants in the German hepatitis C cohort (GECCO) and compared our data to previous findings from the interferon era. Methods Patients with HCV reinfections in the multi-centric GECCO cohort were compared to patients in whom no reinfection occurred. The HCV reinfection incidence rate in MSM was also compared to the incidence rate in the interferon era (using data from the European Acquired Immunodeficiency Syndrome Treatment Network [NEAT]). Results Between January 2014 and April 2018, 48 HCV reinfections occurred in 2298 individuals (2%), with 2346 cured HCV episodes. The median time to reinfection was 500 days (range 16–1160) and the overall HCV reinfection incidence rate was 1.89 per 100 person-years (py; 95% confidence interval [CI], 1.41–2.48). In a multivariate analysis, the transmission risk in MSM was the only independent risk factor of HCV reinfection (odds ratio, 39.3; 95% CI, 4.57–334.40; P =.001). The incidence rate in MSM was 9.02 (95% CI, 6.48–12.26) per 100 py, compared to 1.14 per 100 py in PWID (95% CI,.56–2.09). The incidence rate for a first HCV reinfection in MSM was similar in the direct-acting antiviral era, compared to the interferon era, with a hazard ratio of 1.05 (95% CI,.64–1.74; P =.831). Conclusions HCV reinfection remains a frequent finding among MSM in Germany. In addition to behavioral interventions, early HCV treatment and retreatment should be implemented for this subgroup to prevent HCV transmission. [ABSTRACT FROM AUTHOR]

Published
2020
Full Text
View/download PDF

24. Real-world effectiveness of sofosbuvir-based treatment regimens for chronic hepatitis C genotype 3 infection: Results from the multicenter German hepatitis C cohort (GECCO-03)

Author

Wehmeyer, Malte H., primary, Ingiliz, Patrick, additional, Christensen, Stefan, additional, Hueppe, Dietrich, additional, Lutz, Thomas, additional, Simon, Karl Georg, additional, Schewe, Knud, additional, Boesecke, Christoph, additional, Baumgarten, Axel, additional, Busch, Heiner, additional, Rockstroh, Juergen, additional, Schmutz, Guenther, additional, Kimhofer, Torben, additional, Berger, Florian, additional, Mauss, Stefan, additional, and Schulze zur Wiesch, Julian, additional

Published
2017
Full Text
View/download PDF

25. Effect of Antiviral Therapy for HCV on Lipid Levels

Author

Mauss, Stefan, primary, Berger, Florian, additional, Wehmeyer, Malte H, additional, Ingiliz, Patrick, additional, Hueppe, Dietrich, additional, Lutz, Thomas, additional, Simon, Karl G, additional, Schewe, Knud, additional, Rockstroh, Juergen K, additional, Baumgarten, Axel, additional, and Christensen, Stefan, additional

Published
2017
Full Text
View/download PDF

29. Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A 3-Year Prospective Field Practice Study in Germany

Author

Petersen, Jörg, primary, Heyne, Renate, additional, Mauss, Stefan, additional, Schlaak, Jörg, additional, Schiffelholz, Willibald, additional, Eisenbach, Christoph, additional, Hartmann, Heinz, additional, Wiese, Manfred, additional, Boeker, Klaus, additional, Loehr, Hanns-Friedrich, additional, John, Christine, additional, Leuschner, Maria, additional, Trautwein, Christian, additional, Felten, Gisela, additional, Trein, Andreas, additional, Krause, Wolfgang, additional, Ruppert, Susanne, additional, Warger, Tobias, additional, and Hueppe, Dietrich, additional

Published
2015
Full Text
View/download PDF

30. Cost of treating hepatitis C in Germany: a retrospective multicenter analysis

Author

Stahmeyer, Jona T., Rossol, Siegbert, Bert, Florian, Antoni, Christoph, Demir, Muenevver, Hinrichsen, Holger, Hueppe, Dietrich, Teuber, Gerlinde, Wiebner, Bianka, Wedemeyer, Heiner, Krauth, Christian, Stahmeyer, Jona T., Rossol, Siegbert, Bert, Florian, Antoni, Christoph, Demir, Muenevver, Hinrichsen, Holger, Hueppe, Dietrich, Teuber, Gerlinde, Wiebner, Bianka, Wedemeyer, Heiner, and Krauth, Christian

Abstract

Background Viral hepatitis is major a public health problem affecting millions of people worldwide. Estimates assume 400 000-500 000 people chronically infected with hepatitis C virus (HCV) in Germany. Long-term consequences are the development of liver cirrhosis and hepatocellular carcinoma. The aim of the study was to assess the costs for treating patients with chronic HCV in Germany. Methods We conducted a retrospective multicenter observational study. The design was approved by an ethics committee, and patients were asked for their informed consent. Patients were grouped in four different health states. Healthcare utilization data were extracted from doctor files of six medical centers in Germany. Results Data of 315 patients with chronic HCV were analyzed. The mean age was 49.4 years, 57.5% were male and 67.9% had a genotype 1 infection. The most common routes of transmission were injection drug use (39.0%) and infection through blood products (15.9%). The average total cost was (sic)19 147 including ambulatory care and diagnostics ((sic)1686), pharmaceuticals ((sic)14 875), inpatient care ((sic)1293), and sick leave ((sic)1293). For patients in stable health states (mild and moderate HCV, compensated cirrhosis), costs did not differ significantly and were mainly influenced by antiviral treatment. For patients with decompensated cirrhosis, inpatient care accounted for the largest part of the costs. Conclusion Treatment of HCV patients involves high costs, mainly associated with the length of antiviral therapy. Viral eradication can prevent severe disease stages, which are associated with high costs. It is necessary to follow current guidelines and monitor patients closely to avoid unnecessary costs. (C) 2014 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.

Published
2014

31. Reply

Author

Mauss, Stefan, primary, Hueppe, Dietrich, additional, and Alshuth, Ulrich, additional

Published
2014
Full Text
View/download PDF

33. Sa1050 Efficacy of Boceprevir Based Triple Therapy in Combination With Peginterferon-Alfa-2A Plus Ribavirin (P/R) Under Real Life Conditions in Treatment Experienced Patients Infected With Chronic Hepatitis C, Genotype 1: The PAN Study

Author

Moog, Gero, primary, Mauss, Stefan, additional, Hueppe, Dietrich, additional, Spengler, Ulrich, additional, Schott, Eckart, additional, Eisenbach, Christoph, additional, Schober, Andreas, additional, Heyne, Renate, additional, Jung, Maria-Christina, additional, Teuber, Gerlinde, additional, Doss, Margareta Frank, additional, Rössle, Martin, additional, Pape, Stefan, additional, Schuchmann, Marcus, additional, Alshuth, Ulrich, additional, and Buggisch, Peter, additional

Published
2013
Full Text
View/download PDF

34. Sa1051 Boceprevir Based Triple Therapy in Combination With Peginterferon-Alfa-2A Plus Ribavirin (P/R) Under Real Life Conditions in Treatment NaïVE Patients Infected With Chronic Hepatitis C, Genotype 1: An Interim Analysis At Week 12 After Start of Treatment

Author

Moog, Gero, primary, Mauss, Stefan, additional, Hueppe, Dietrich, additional, Spengler, Ulrich, additional, Schott, Eckart, additional, Eisenbach, Christoph, additional, Schober, Andreas, additional, Heyne, Renate, additional, Jung, Maria-Christina, additional, Teuber, Gerlinde, additional, Doss, Margareta Frank, additional, Rössle, Martin, additional, Pape, Stefan, additional, Schuchmann, Marcus, additional, Alshuth, Ulrich, additional, and Buggisch, Peter, additional

Published
2013
Full Text
View/download PDF

35. Sa1034 Sustained Responders After Antiviral Treatment of Chronic Hepatitis C Have a Better Quality of Life and Productivity Independent of Genotype, Age and Opioid Maintenance

Author

Mauss, Stefan, primary, Petersen, Joerg, additional, Witthoeft, Thomas, additional, Busch, Heiner W., additional, Christensen, Stefan, additional, Zehnter, Elmar, additional, John, Christine, additional, Gölz, Jörg, additional, Hartmann, Dagmar, additional, Dreher, Bernd, additional, Bilzer, Manfred, additional, and Hueppe, Dietrich, additional

Published
2013
Full Text
View/download PDF

36. 723 Substantial Renal Impairment Is Not Infrequent in HCV Patients Under Triple Therapy With Telaprevir or Boceprevir

Author

Mauss, Stefan, primary, Eisenbach, Christoph, additional, Heyne, Renate, additional, Moog, Gero, additional, Lutz, Thomas, additional, Naumann, Uwe, additional, Geissler, Michael, additional, Mordeja, Matthias, additional, Herold, Christoph, additional, Simon, Karl Georg, additional, Milicic-Ouakili, Kerstin, additional, Buggisch, Peter, additional, and Hueppe, Dietrich, additional

Published
2013
Full Text
View/download PDF

37. Sa1041 Triple Therapy Under Real Life Conditions: Telaprevir (TVR) and Boceprevir (BOC) in Combination With Peginterferon-Alfa-2A Plus Ribavirin (P/R) in Treatment Experienced Patients Infected With Chronic Hepatitis C, Genotype 1. the PAN Study

Author

Moog, Gero, primary, Mauss, Stefan, additional, Hueppe, Dietrich, additional, Spengler, Ulrich, additional, Schott, Eckart, additional, Eisenbach, Christoph, additional, Schober, Andreas, additional, Heyne, Renate, additional, Jung, Maria-Christina, additional, Teuber, Gerlinde, additional, Doss, Margareta Frank, additional, Rössle, Martin, additional, Pape, Stefan, additional, Schuchmann, Marcus, additional, Alshuth, Ulrich, additional, and Buggisch, Peter, additional

Published
2013
Full Text
View/download PDF

38. Sa1052 Triple Therapy Under Real Life Conditions: Telaprevir (TVR) in Combination With Peginterferon-Alfa-2A Plus Ribavirin (P/R) in NaïVE Patients Infected With Chronic Hepatitis C, Genotype 1. The PAN Study

Author

Moog, Gero, primary, Mauss, Stefan, additional, Hueppe, Dietrich, additional, Spengler, Ulrich, additional, Schott, Eckart, additional, Eisenbach, Christoph, additional, Schober, Andreas, additional, Heyne, Renate, additional, Jung, Maria-Christina, additional, Teuber, Gerlinde, additional, Doss, Margareta Frank, additional, Rössle, Martin, additional, Pape, Stefan, additional, Schuchmann, Marcus, additional, Alshuth, Ulrich, additional, and Buggisch, Peter, additional

Published
2013
Full Text
View/download PDF

39. Sa1052 Thyroid Dysfunction Triggered by Peginterferon Alfa-2B / Ribavirin Treatment of Chronic HCV Genotype 1 Infection Favors Sustained Virologic Response (SVR) by Reducing

Author

Mauss, Stefan, primary, Hueppe, Dietrich, additional, Zehnter, Elmar, additional, Manns, Michael P., additional, Teuber, Gerlinde, additional, Dahhan, Tarek, additional, Meyer, Ulrike, additional, Witthöft, Thomas, additional, Moeller, Bernd, additional, Dikopoulos, Nektarios, additional, Brack, Jochen, additional, Dach, Kristina, additional, Stade, Barbara, additional, and Bilzer, Manfred, additional

Published
2012
Full Text
View/download PDF

42. Longterm Benefits of Sustained Virological Response (SVR) in Patients With Chronic Hepatitis C (CHC) Virus Infection: The German Lotos Study

Author

Reimer, Jens, primary, Hueppe, Dietrich, additional, Sandow, Petra, additional, Naumann, Uwe, additional, Gölz, Jörg, additional, Christensen, Stefan, additional, Busch, Heiner W., additional, Lutz, Thomas, additional, Hey, Karl-Heinz, additional, Grüngreiff, Kurt, additional, Leuschner, Maria, additional, Felten, Gisela, additional, Bokemeyer, Bernd, additional, Link, Ralph, additional, Stoll, Sabine, additional, and Wedemeyer, Heiner, additional

Published
2011
Full Text
View/download PDF

43. Predictive Factors of Thrombocytopenia in Treatment of Chronic Hepatitis C (CHC) Patients With Peginterferon Alfa-2a (40KD) and Ribavirin

Author

Mauss, Stefan, primary, Schober, Andreas, additional, Lutz, Thomas, additional, Moog, Gero, additional, Schuchmann, Marcus, additional, Heyne, Renate, additional, John, Christine, additional, Schiffelholz, Willibold, additional, Baumgarten, Axel, additional, Hey, Karl-Heinz, additional, Eisenbach, Christoph, additional, Teuber, Gerlinde, additional, Schmidt, Wolfgang, additional, Bruch, Harald-Robert, additional, Geyer, Peter, additional, Alshuth, Ulrich, additional, and Hueppe, Dietrich, additional

Published
2011
Full Text
View/download PDF

44. High SVR-Rates in Patients With HCV Genotype 1-Infection, Who Are Dually Infected With Either Genotype 2 or 3 and Treated With PEG-IFNα-2B and Ribavirin

Author

Mauss, Stefan, primary, Teuber, Gerlinde, additional, Zehnter, Elmar, additional, Manns, Michael P., additional, Dahhan, Tarek, additional, Meyer, Ulrike, additional, Moeller, Bernd, additional, Dikopoulos, Nektarios, additional, Witthoeft, Thomas, additional, Bilzer, Manfred, additional, Tossing, Gudrun, additional, and Hueppe, Dietrich, additional

Published
2011
Full Text
View/download PDF

45. Dose Reduction of Peginterferon Alfa-2a (PEG) in Combination With Ribavirin (RBV) in Chronic Hepatitis C (CHC) Patients: Impact on Virological Response Under Real Life Conditions

Author

Boeker, Klaus, primary, Mauss, Stefan, additional, Hueppe, Dietrich, additional, Schuchmann, Marcus, additional, Schiffelholz, Willibold, additional, Baumgarten, Axel, additional, Eisenbach, Christoph, additional, Rössle, Martin, additional, Buggisch, Peter, additional, Lohmeyer, Juergen, additional, Witthoeft, Thomas, additional, Moeller, Bernd, additional, Loehr, Matthias, additional, Schott, Eckart, additional, Alshuth, Ulrich, additional, and Zehnter, Elmar, additional

Published
2011
Full Text
View/download PDF

46. T1993 Comparison of the Efficacy of Peginterferon Alfa-2a and -2B Plus Ribavirin in the Treatment of Chronic Hepatitis C Patients in Daily Routine: Results From Practice

Author

Witthoeft, Thomas, primary, Mauss, Stefan, additional, Hueppe, Dietrich, additional, John, Christine, additional, Heyne, Renate, additional, Moeller, Bernd, additional, Dikopoulos, Nektarios, additional, Baumgarten, Axel, additional, Teuber, Gerlinde, additional, Link, Ralph, additional, and Herrmann, Andreas, additional

Published
2010
Full Text
View/download PDF

47. M1794 Efficacy and Tolerability of Peginterferon Alfa-2a (40KD) (PEG) and Ribavirin (RBV) in Genotype 5 and 6 Patients with Chronic Hepatitis C Under Real Life Conditions

Author

Hueppe, Dietrich, primary, Zehnter, Elmar, additional, Mauss, Stefan, additional, Kaiser, Stephan, additional, Schober, Andreas, additional, Schuchmann, Marcus, additional, Boeker, Klaus, additional, Moog, Gero, additional, Schiffelholz, Willibold, additional, Pape, Stefan, additional, Heyne, Renate, additional, Ackermann, Frank, additional, Schmidt, Wolfgang, additional, John, Christine, additional, Lohmeyer, Juergen, additional, Hey, Karl-Heinz, additional, and Alshuth, Ulrich, additional

Published
2009
Full Text
View/download PDF

49. M1791 Role of Rvr and Viral Load On SVR in Treatment of GT3 Hepatitis C Patients with Peginterferon Alfa-2a (PEG) and Ribavirin (RBV) in Real Life

Author

Zehnter, Elmar, primary, Hueppe, Dietrich, additional, Kaiser, Stephan, additional, Schober, Andreas, additional, Schuchmann, Marcus, additional, Boeker, Klaus, additional, Moog, Gero, additional, Schiffelholz, Willibold, additional, Pape, Stefan, additional, Heyne, Renate, additional, Ackermann, Frank, additional, Schmidt, Wolfgang, additional, John, Christine, additional, Lohmeyer, Juergen, additional, Hey, Karl-Heinz, additional, Alshuth, Ulrich, additional, and Mauss, Stefan, additional

Published
2009
Full Text
View/download PDF

50. S1006 Efficacy and Safety of Peginterferon Alfa-2a or −2b Plus Ribavirin in the Routine Daily Treatment of Chronic Hepatitis C Patients in Germany: the Practice Study

Author

Witthoeft, Thomas, primary, Hueppe, Dietrich, additional, John, Christine, additional, Goelz, Joerg, additional, Meyer, Ulrike, additional, Heyne, Renate, additional, Moeller, Bernd, additional, Link, Ralph, additional, Teuber, Gerlinde, additional, Sworszt, Slawomir, additional, Herrmann, Andreas, additional, Wollschlaeger, Andreas, additional, Baumgarten, Axel, additional, Simon, Karl-Georg, additional, Cordes, Joerg, additional, Moog, Gero, additional, Dikopoulos, Nektarios, additional, and Mauss, Stefan, additional

Published
2008
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results